AI-generated analysis. Always verify with the original filing.
Movano Inc. (Nasdaq: MOVE) is a technology company developing a healthcare platform to deliver medical-grade data through consumer health devices, such as the Evie Ring. The company is currently pursuing a strategic merger with Corvex, Inc., an AI cloud computing company specializing in GPU-accelerated infrastructure for AI workloads. This S-1/A filing registers the resale of 545,456 shares of Common Stock issuable upon conversion of Series A Preferred Stock held by Selling Stockholders, who provided $3.0 million in bridge financing. Movano will not receive any proceeds from this resale offering. The merger is structured as a reverse recapitalization where Corvex will be the accounting acquirer, with Corvex securityholders expected to own approximately 94.9% of the combined company. Corvex generated $4.9 million in revenue for the nine months ended September 30, 2025, while Movano reported a net loss of $12.4 million for the same period. The combined entity aims to capitalize on the growing demand for AI infrastructure.
Offering Amount
$50.00B
Shares Offered
2,500,000,000
Price Range
$15.00 – $25.00
Shares Offered
545,456
Share Type
Common Stock
Exchange
Nasdaq Capital Market
Ticker
MOVE
Use of Proceeds: We will not receive any proceeds from the resale of the Shares by the Selling Stockholders.
Movano Inc. is developing a platform to deliver purpose-driven healthcare solutions to bring medical-grade, high-quality data to the forefront of consumer health devices. It is currently merging with Corvex, Inc., an AI cloud computing company specializing in GPU accelerated infrastructure for AI workloads.